AptarGroup, Inc.
AptarGroup, Inc. price
About AptarGroup, Inc.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
- Stock ticker
- ATR
- Company
- AptarGroup, Inc.
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 12
- Launch date
- Apr 23, 1993
- Listed exchange
- NYSE
Financials
Summary: ATR reported Revenue of 1.03B (+6.26%), beating expectations; EPS of 1.42 (-14.46%), beating expectations.
Dividends
AptarGroup, Inc. conversion tables
 |  |
|---|---|
| 0.5 ATR | 60.9 USD |
| 1 ATR | 121.81 USD |
| 5 ATR | 609.05 USD |
| 10 ATR | 1,218.1 USD |
| |
|---|---|
| 0.5 USD | 0.0041048 ATR |
| 1 USD | 0.0082095 ATR |
| 5 USD | 0.041048 ATR |
| 10 USD | 0.082095 ATR |
More to explore
FAQ
ATR is trading at $121.81, +1.15% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ATR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ATR is currently trading at $121.81, +1.15% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ATR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ATR's P/E ratio is currently 21.81 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ATR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ATR's historical range and other companies in the Healthcare sector.
AptarGroup, Inc.'s market cap is currently 7.7B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.